Key result
ADIPOQ gene variant linked to ~8-fold higher CAD risk in Asian patients with T2DM.
Why the study?
Evidence on shared genetic factors contributing to CAD risk in Asian patients with T2DM remains fragmented, with limited focus on population-specific variants.
Do specific genetic variants affect the risk of coronary artery disease in Asian patients with type 2 diabetes mellitus?
Do specific genetic variants affect the risk of coronary artery disease in Asian patients with type 2 diabetes mellitus?
Specific genetic variants, rather than a broad polygenic signal, are associated with coronary artery disease risk in Asian patients with type 2 diabetes, highlighting potential targets for precision risk stratification.
May support targeted ADIPOQ testing for CAD risk stratification in Asian T2DM; leaves open prospective validation before practice change.
Background/Objectives: Type 2 diabetes mellitus (T2DM) significantly elevates the risk of coronary artery disease (CAD), particularly in Asian populations where both conditions are epidemic. While shared genetic factors contribute to this comorbidity, evidence from Asian cohorts remains fragmented, with limited focus on population-specific variants. This meta-analysis synthesizes evidence on genetic variants associated with CAD risk in Asian patients with T2DM. Methods: We systematically searched several databases according to the PRISMA statement and checklist. Pooled odds ratios (ORs) with corresponding 95% confidence intervals (CIs) were calculated using random-effects models, with heterogeneity assessed via I2 and Cochran’s Q, and publication bias via funnel plots and Egger’s test. Results: In total, data on 11,268 subjects were reviewed, including 4668 cases and 6600 controls. Among 950 identified studies, 18 met eligibility criteria, and 14 studies provided sufficient data for the meta-analysis. The random-effects pooled estimate across all studied variants was not statistically significant (OR = 1.16 [95% CI: 0.68–2.00]; z = 0.56, p = 0.58). However, analysis of individual loci revealed gene-specific associations with CAD among this population: PCSK1 gene (OR = 2.12 [95% CI: 1.26–3.52]; p < 0.05; weight = 8.77%), GLP1R gene (OR = 2.25 [95% CI: 1.27–3.97]; p < 0.01; weight = 8.62%). ADIPOQ gene (OR = 8.00 [95% CI: 2.34–27.14]; p < 0.01; weight = 6.35%). Several genes were associated with an elevated risk of CAD: PCSK1 gene (OR = 2.12 [95% CI: 1.26–3.52]; p < 0.05; weight = 8.77%), GLP1R gene (OR = 2.25 [95% CI: 1.27–3.97]; p < 0.01; weight = 8.62%) and ADIPOQ gene (OR = 8.00 [95% CI: 2.34–27.14]; p < 0.01; weight = 6.35%). Several genes were associated with possible protective effects: ACE gene (OR = 0.41 [95% CI: 0.23–0.73]; p < 0.01; weight = 8.57%), Q192R gene (OR = 0.20 [95% CI: 0.08–0.52]; p < 0.001; weight = 7.41%). Heterogeneity was substantial (τ2 = 0.78; I2 = 81.95%; Q (13) = 64.67, p < 0.001). Conclusions: This first meta-analysis of genetic variants associated with CAD in Asian populations with T2DM identified specific locus-level associations implicating lipid metabolism, incretin signaling, and oxidative stress pathways. The lack of a significant pooled effect, alongside high heterogeneity, underscores the complexity and population-specific nature of this genetic architecture. These findings suggest that effective precision risk stratification may depend more on specific variants than on a broad polygenic signal, highlighting the need for further research in a larger, distinct sample size.
No takes yet. Share an insight, caveat, or question.
Kabibulatova et al. (2026) studied this question. The ADIPOQ gene variant was associated with an 8.00-fold increase in CAD risk in Asian patients with T2DM (OR = 8.00, 95% CI: 2.34–27.14; p < 0.01).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: